(Press-News.org) New Rochelle, NY, August 9, 2012—Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration (FDA) has created a database from 40 clinical studies to assess gender differences in the efficacy of antiretroviral treatments. The results of this study are presented in an article in AIDS Patient Care and STDs, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the AIDS Patient Care and STDs website at http://www.liebertpub.com/apc.
Guoxing Soon and coauthors from the FDA and University of Texas Southwestern Medical Center, Dallas, TX, found that women represented only about 20% of the subjects in randomized clinical trials submitted to the FDA between 2000 and 2008. The article "Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000-2008)" compares the effectiveness of anti-HIV drug regimens reported for women versus men overall and among various subgroups.
The authors found no statistically or clinical significant differences between women and men in outcomes with regard to viral load after 48 weeks. However, they did report significant gender differences favoring males based on subgroup analyses.
"This is a critical area of research in terms of developing new HIV therapies," says Editor-in-Chief Jeffrey Laurence, MD, Director of the Laboratory for AIDS Virus Research at Weill Medical College of Cornell University, New York, NY. "Mounting evidence indicates that metabolism of certain drugs varies in men vs. women, and side effects that interfere with adherence to these medications may also be manifest differently."
INFORMATION:
About the Journal
AIDS Patient Care and STDs is the leading journal for clinicians, enabling them to keep pace with the latest developments in this evolving field. Published monthly in print and online, the Journal spans the full spectrum of adult and pediatric HIV disease, diagnosis, treatment, prevention, and education. Tables of content and a sample issue may be viewed on the AIDS Patient Care and STDs website at http://www.liebertpub.com/apc.
About the Publisher
Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Research and Human Retroviruses, Journal of Palliative Medicine, and Viral Immunology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals and books is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101
Are there gender differences in anti-HIV drug efficacy?
2012-08-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Potential Nipah vaccine passes primate test
2012-08-09
Researchers have successfully tested a vaccine for the deadly Nipah virus in monkeys, raising hopes that it could provide similar protection for humans.
With greater than a 75 percent fatality rate and the ability to be transmitted directly from person to person, Nipah has long been a significant concern for infectious-disease experts. The virus, which is carried naturally by fruit bats, was first discovered in Malaysia in 1998. Outbreaks have occurred in nearly every year since, in Singapore, Bangladesh and India.
"This vaccine is based on a protein from Hendra virus, ...
University of Tennessee professor releases weight management product
2012-08-09
VIDEO:
How would you like to experience the effects of running three miles or staving off Type 2 diabetes without making drastic changes in your lifestyle? With nutrition supplements developed by...
Click here for more information.
How would you like to experience the effects of running three miles or staving off type two diabetes without making drastic changes in your lifestyle? With nutrition supplements developed by a professor at the University of Tennessee, Knoxville, ...
Source of conflict: Study finds factors that can shape divorced mothers' co-parenting experiences
2012-08-09
SALINA, KAN. -- The type of relationship a woman has with her ex-partner is a factor in how the couple shares custody of children, according to a Kansas State University expert on postdivorce and co-parenting relationships.
In a study of divorced or separated mothers sharing physical custody of their children with their former partners, Mindy Markham, assistant professor of family studies and human services on the university's Salina campus, identified three patterns of co-parenting -- continuously contentious, always amicable and bad to better -- as well as negative ...
Hormone acting drugs + uterine artery embolization offers nonsurgical treatment for uterine fibroids
2012-08-09
Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice –hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile.
The study, conducted at the Yonsei University College of Medicine in Seoul South Korea, included 40 women with 10 cm or larger uterine fibroids. Twelve of the women received gonadotropin-releasing hormone (GnRH) agonists to shrink their fibroids before undergoing uterine artery embolization, said Man Deuk Kim, MD, PhD, lead ...
The making and unmaking of stem-like, aggressive breast cancer cells
2012-08-09
Breast cancers that depend on the hormones estrogen and progesterone are susceptible to treatments targeting these hormones. Take away this dependence and you lose a valuable treatment option. A University of Colorado Cancer Center study published as a featured article in the journal Oncogene shows how progesterone does just this – by suppressing a key microRNA, progestins return breast cancer cells to a stem-cell-like state in which they haven't yet differentiated, and are thus more resistant to chemotherapies and more likely to carry a poor prognosis.
"The reason we ...
New 3-D map of massive galaxies, distant black holes offers clues to dark matter and energy
2012-08-09
The Sloan Digital Sky Survey III (SDSS-III) has released the largest-ever three-dimensional map of massive galaxies and distant black holes, helping astronomers better explain the mysterious "dark matter" and "dark energy" that make up 96 percent of the universe. According to SDSS-III scientific spokesperson and University of Pittsburgh assistant professor of physics and astronomy Michael Wood-Vasey, scientists using the map—titled Data Release 9 (DR9)— can retrace the Universe's history over the last seven billion years. Wood-Vasey cowrote the DR9 summary paper featured ...
Chronic exposure to staph bacteria may be risk factor for lupus, Mayo study finds
2012-08-09
ROCHESTER, Minn. -- Chronic exposure to even small amounts of staph bacteria could be a risk factor for the chronic inflammatory disease lupus, Mayo Clinic research shows. Staph, short for Staphylococcus aureus, is a germ commonly found on the skin or in the nose, sometimes causing infections. In the Mayo study, mice were exposed to low doses of a protein found in staph and developed a lupus-like disease, with kidney disease and autoantibodies like those found in the blood of lupus patients.
The findings are published online this month in The Journal of Immunology. ...
Astronomers release the largest ever 3-D map of the sky
2012-08-09
VIDEO:
This is an animated flight through the universe as seen by SDSS. There are close to 400,000 galaxies in the animation, which places zoomed-in images of nearby galaxies at the...
Click here for more information.
The Sloan Digital Sky Survey III (SDSS-III) has released the largest three-dimensional map of massive galaxies and distant black holes ever created. The new map pinpoints the locations and distances of over a million galaxies. It covers a total volume equivalent ...
Wiki where you work?
2012-08-09
Do corporate wikis work? Two University of Alberta researchers say they can, providing they fit the corporation's culture and provide for the needs and interests of their users and editors.
PhD candidate Lisa Yeo and Ofer Arazy, an assistant professor in the Alberta School of Business, say that using wikis as a form of corporate knowledge management can be beneficial. However, some concessions need to be made in terms of how wiki "knowledge" is posted to support people's needs for recognition with their company. If companies want their wiki to work, it cannot be held ...
Simple mathematical computations underlie brain circuits
2012-08-09
CAMBRIDGE, MA -- The brain has billions of neurons, arranged in complex circuits that allow us to perceive the world, control our movements and make decisions. Deciphering those circuits is critical to understanding how the brain works and what goes wrong in neurological disorders.
MIT neuroscientists have now taken a major step toward that goal. In a new paper appearing in the Aug. 9 issue of Nature, they report that two major classes of brain cells repress neural activity in specific mathematical ways: One type subtracts from overall activation, while the other divides ...